BWV 401
Alternative Names: BWV-401; Chlamydia vaccine - OnconetixLatest Information Update: 20 Dec 2023
At a glance
- Originator University of Texas Health Science Center at San Antonio
- Developer Onconetix; University of Texas Health Science Center at San Antonio
- Class Antibacterials; Attenuated vaccines; Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Chlamydial infections
Most Recent Events
- 18 Dec 2023 Proteomedix has merged with Blue Water Biotech to form Onconetix
- 24 Apr 2023 Blue Water Vaccines is now called Blue Water Biotech
- 12 Apr 2023 Blue water vaccines signs a sponsored research agreement with the University of Texas Health Science Center at San Antonio to fund a non-human primate (NHP) study